Own Products & Pipeline
In addition to the family of Omega-3 fatty acids the KD Pharma Group is continuously developing innovative drugs for unmet medical needs.
Our actual pipeline:
- ALFA Gastro-resistant Capsules for the treatment of Familial Adenomatous Polyposis (FAP), phase III
- ALFA Gastro-resistant Capsules for the treatment of Ulcerative Colitis (UC)
Are you interested in becoming our Licensing Partner? Please contact us at: email@example.com